-+ 0.00%
-+ 0.00%
-+ 0.00%

Carlsmed Announces U.S. Commercial Launch Of Aprevo Technology Platform For Cervical Fusion Surgeries

Benzinga·12/03/2025 12:10:40
Listen to the news

Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced the U.S. commercial launch of its aprevo® Technology Platform for cervical fusion surgeries. Surgeons involved in the clinical evaluation will also present early clinical data at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting in Washington, D.C., December 3-6, 2025.

The aprevo® Cervical Interbody System expands Carlsmed's personalized spine platform, which combines AI-driven preoperative planning with 3D-printed, patient-specific implants tailored to each patient's anatomy and pathology. The cervical system builds upon the success of the aprevo® lumbar platform, which to date has demonstrated lower complication rates and fewer revision surgeries compared to standard stock implants.